May 5, 2010 -- San Diego --
Volcano Corporation (Nasdaq: VOLC), a leading developer and manufacturer
of precision intravascular therapy guidance tools designed to
enhance the diagnosis and treatment of coronary and peripheral
vascular disease, said today that it will be participating in
the Bank of America Merrill Lynch Health Care Conference on Tuesday,
May 11.
The presentation by Scott Huennekens, president and chief
executive officer, will begin at 9:20 a.m., Eastern Daylight
Time (6:20 a.m., Pacific Daylight Time). |